日科化学
(300214)
| 流通市值：58.48亿 | | | 总市值：58.48亿 |
| 流通股本：4.65亿 | | | 总股本：4.65亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,905,536,476.8 | 912,958,078.53 | 3,741,849,463.53 | 2,826,848,472.82 |
| 营业总成本 | 1,881,139,906.56 | 916,887,779.2 | 3,752,618,132.45 | 2,859,520,083.82 |
| 其他经营收益 | | | | |
| 营业利润 | 46,662,844.18 | 5,560,753.2 | -3,302,512.36 | -3,497,678.87 |
| 利润总额 | 45,417,682.85 | 5,203,140.73 | -4,160,865.02 | -5,066,853.58 |
| 净利润 | 34,975,068.69 | 4,080,248.68 | -35,066,223.15 | 511,328.06 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 34,975,068.69 | 4,080,248.68 | -35,066,223.15 | 511,328.06 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,876,660,158.65 | 1,910,983,291 | 1,880,855,000.85 | 1,748,348,160.74 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,161,065,957.18 | 3,106,570,719.26 | 3,162,047,223.37 | 3,222,105,010.42 |
| 资产总计 | 5,037,726,115.83 | 5,017,554,010.26 | 5,042,902,224.22 | 4,970,453,171.16 |
| 流动负债: | | | | |
| 流动负债合计 | 1,895,160,777.69 | 1,994,008,489.77 | 1,904,370,973.38 | 1,811,657,866.06 |
| 非流动负债: | | | | |
| 非流动负债合计 | 616,843,609.67 | 531,318,799.68 | 652,094,782.5 | 615,574,255.66 |
| 负债合计 | 2,512,004,387.36 | 2,525,327,289.45 | 2,556,465,755.88 | 2,427,232,121.72 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,427,401,183.79 | 2,394,486,040.16 | 2,390,698,356.18 | 2,421,387,251.7 |
| 股东权益合计 | 2,525,721,728.47 | 2,492,226,720.81 | 2,486,436,468.34 | 2,543,221,049.44 |
| 负债和股东权益合计 | 5,037,726,115.83 | 5,017,554,010.26 | 5,042,902,224.22 | 4,970,453,171.16 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,762,042,143.71 | 831,618,073.52 | 3,604,801,041.78 | 2,665,756,359 |
| 经营活动现金流出小计 | 1,684,015,736.98 | 826,791,496.35 | 3,473,676,878.85 | 2,600,837,862.26 |
| 经营活动产生的现金流量净额 | 78,026,406.73 | 4,826,577.17 | 131,124,162.93 | 64,918,496.74 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 36,715,158.93 | 1,723,676.91 | 112,373,738.97 | 133,015,875.48 |
| 投资活动现金流出小计 | 80,569,955.15 | 21,061,636.66 | 328,274,108.42 | 141,559,353.72 |
| 投资活动产生的现金流量净额 | -43,854,796.22 | -19,337,959.75 | -215,900,369.45 | -8,543,478.24 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 564,952,876.49 | 341,456,618.05 | 1,122,764,235.89 | 627,299,324.59 |
| 筹资活动现金流出小计 | 564,717,831.31 | 274,123,407.61 | 1,027,201,899.07 | 817,301,173.55 |
| 筹资活动产生的现金流量净额 | 235,045.18 | 67,333,210.44 | 95,562,336.82 | -190,001,848.96 |
| 汇率变动对现金及现金等价物的影响 | -2,593,981.08 | -1,289,671.51 | 1,442,370.92 | 1,504,343.1 |
| 现金及现金等价物净增加额 | 31,812,674.61 | 51,532,156.35 | 12,228,501.22 | -132,122,487.36 |
| 期末现金及现金等价物余额 | 281,191,974.06 | 288,682,954.58 | 249,379,299.45 | 105,028,310.87 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 31,812,674.61 | - | 12,228,501.22 | - |